| 缩写名/全名 |
CANCER MANAG RES
Cancer Management and Research |
||||||||||||||||
| ISSN号 | 1179-1322 | ||||||||||||||||
| 研究方向 | - | ||||||||||||||||
| 影响因子 | 2015:0, 2016:3.851, 2017:3.702, 2018:2.243, 2019:2.886, | ||||||||||||||||
| 出版国家 | UNITED STATES | ||||||||||||||||
| 出版周期 | |||||||||||||||||
| 年文章数 | 947 | ||||||||||||||||
| 出版年份 | 0 | ||||||||||||||||
| 是否OA | Yes | ||||||||||||||||
| 审稿周期(仅供参考) | |||||||||||||||||
| 录用比例 | |||||||||||||||||
| 投稿链接 | https://www.dovepress.com/submit_step_1.php | ||||||||||||||||
| 投稿官网 | https://www.dovepress.com/cancer-management-and-research-journal | ||||||||||||||||
| h-index | 32 | ||||||||||||||||
| CiteScore |
|
||||||||||||||||
| PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1179-1322%5BISSN%5D | ||||||||||||||||
| 中科院SCI期刊分区 （ 2018年新版本） |
|
||||||||||||||||
| 中科院SCI期刊分区 （ 2020年新版本） |
|
| 中国学者近期发表的论文 | |
| 1. | Survival benefit of higher fraction dose delivered by three-dimensional conformal radiotherapy in hepatocellular carcinoma smaller than 10 cm in size. Author: Su F1, Chen K1, Liang Z1, Qu S1, Li L1, Chen L1, Yang Y1, Wu C1, Liang X1, Zhu X1. Journal: Cancer Manag Res. 2019 Apr 30;11:3791-3799. doi: 10.2147/CMAR.S179540. eCollection 2019. PubMed DOI |
| 2. | MicroRNA-145 inhibits growth of laryngeal squamous cell carcinoma by targeting the PI3K/Akt signaling pathway. Author: Ye D1,2, Zhou C2, Deng H2, Lin L2, Zhou S1. Journal: Cancer Manag Res. 2019 Apr 30;11:3801-3812. doi: 10.2147/CMAR.S199291. eCollection 2019. PubMed DOI |
| 3. | lncRNA CADM1-AS1 inhibits cell-cycle progression and invasion via PTEN/AKT/GSK-3β axis in hepatocellular carcinoma. Author: Wang F1, Qi X1,2, Li Z1,2, Jin S1, Xie Y1, Zhong H1,2. Journal: Cancer Manag Res. 2019 Apr 30;11:3813-3828. doi: 10.2147/CMAR.S197673. eCollection 2019. PubMed DOI |
| 4. | Functional variants of lncRNA LINC00673 and gastric cancer susceptibility: a case-control study in a Chinese population. Author: Zhao K1, Zhang R2, Li T3, Xiong Z1. Journal: Cancer Manag Res. 2019 May 1;11:3861-3868. doi: 10.2147/CMAR.S187011. eCollection 2019. PubMed DOI |
| 5. | The influence of sex on the prognostic value of body mass index in non-metastasis renal cell carcinoma. Author: Zheng Y1, Bao L2, Chen J3, Pan Y4, Wang Q4, Chen L5, Gao X6. Journal: Cancer Manag Res. 2019 May 1;11:3869-3886. doi: 10.2147/CMAR.S197457. eCollection 2019. PubMed DOI |
| 6. | Disulfiram inhibits epithelial-mesenchymal transition through TGFβ-ERK-Snail pathway independently of Smad4 to decrease oral squamous cell carcinoma metastasis. Author: Bu W1, Wang Z1, Meng L1, Li X2, Liu X1, Chen Y1, Xin Y3, Li B4, Sun H1. Journal: Cancer Manag Res. 2019 May 1;11:3887-3898. doi: 10.2147/CMAR.S199912. eCollection 2019. PubMed DOI |
| 7. | Expression profiles and prognostic significance of RNA N6-methyladenosine-related genes in patients with hepatocellular carcinoma: evidence from independent datasets. Author: Zhou Y1, Yin Z1, Hou B1, Yu M1, Chen R2, Jin H1, Jian Z1. Journal: Cancer Manag Res. 2019 May 1;11:3921-3931. doi: 10.2147/CMAR.S191565. eCollection 2019. PubMed DOI |
| 8. | Small RNA sequencing reveals a novel tsRNA-26576 mediating tumorigenesis of breast cancer. Author: Zhou J1, Wan F1, Wang Y1, Long J1, Zhu X2,3. Journal: Cancer Manag Res. 2019 May 2;11:3945-3956. doi: 10.2147/CMAR.S199281. eCollection 2019. PubMed DOI |
| 9. | Incidence risk of PD-1/PD-L1 related diarrhea in non-small cell lung cancer (NSCLC) patients: a systematic review and meta-analysis. Author: Zhang C1, Zhang S2, Xu D3, Liu R4, Zhu Q5, Zhao Y6, Mao Y7, Tian Y3. Journal: Cancer Manag Res. 2019 May 2;11:3957-3969. doi: 10.2147/CMAR.S202756. eCollection 2019. PubMed DOI |
| 10. | High systemic immune-inflammation index represents an unfavorable prognosis of malignant pleural mesothelioma. Author: Ma M1, Yu N2, Wu B1. Journal: Cancer Manag Res. 2019 May 2;11:3973-3979. doi: 10.2147/CMAR.S201269. eCollection 2019. PubMed DOI |
|
|
